Finally, mutations in DNA methylation enzymes (DNMT3A, TET2, IDH1 and IDH2) have been found in ~44% of AML [48], and only in 16% of AP/BC-CML [51]. The gene discussed is TET2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.